Multiple Arrhythmic Syndromes in a Newborn, Owing to a Novel Mutation in SCN5A

Overview

Journal Can J Physiol Pharmacol

Specialties Pharmacology
Physiology

Date 2011 Sep 8

PMID 21895525

Citations 5

Authors

Kirstine Calloe

Nicole Schmitt

Soren Grubb

Ryan Pfeiffer

Jens-Peter David

Ronald Kanter

Jonathan M Cordeiro

Charles Antzelevitch

Affiliations

Soon will be listed here.

Abstract

Background: Mutations in the SCN5A gene have been linked to Brugada syndrome (BrS), conduction disease, Long QT syndrome (LQT3), atrial fibrillation (AF), and to pre- and neonatal ventricular arrhythmias.

Objective: The objective of this study is to characterize a novel mutation in Na(v)1.5 found in a newborn with fetal chaotic atrial tachycardia, post-partum intraventricular conduction delay, and QT interval prolongation.

Methods: Genomic DNA was isolated and all exons and intron borders of 15 ion-channel genes were sequenced, revealing a novel missense mutation (Q270K) in SCN5A. Na(v)1.5 wild type (WT) and Q270K were expressed in CHO-K1 with and without the Na(v)β1 subunit. Results. Patch-clamp analysis showed ∼40% reduction in peak sodium channel current (I(Na)) density for Q270K compared with WT. Fast and slow decay of I(Na) were significantly slower in Q270K. Steady-state activation and inactivation of Q270K channels were shifted to positive potentials, and window current was increased. The tetrodotoxin-sensitive late I(Na) was increased almost 3-fold compared with WT channels. Ranolazine reduced late I(Na) in WT and Q270K channels, while exerting minimal effects on peak I(Na).

Conclusion: The Q270K mutation in SCN5A reduces peak I(Na) while augmenting late I(Na), and may thus underlie the development of atrial tachycardia, intraventricular conduction delay, and QT interval prolongation in an infant.

Citing Articles

Atrial Arrhythmia and Bradycardia as a Presentation of Congenital Long QT Syndrome.

Sueblinvong V, Zhang S, Varga P Pediatr Cardiol. 2024; .

PMID: 38990321 DOI: 10.1007/s00246-024-03577-8.

Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome.

Nasilli G, Yiangou L, Palandri C, Cerbai E, Davis R, Verkerk A Europace. 2023; 25(6).

PMID: 37369559 PMC: 10299896. DOI: 10.1093/europace/euad154.

Genetics and Epigenetics of Atrial Fibrillation.

Lozano-Velasco E, Franco D, Aranega A, Daimi H Int J Mol Sci. 2020; 21(16).

PMID: 32784971 PMC: 7460853. DOI: 10.3390/ijms21165717.

Rare NaV1.7 variants associated with painful diabetic peripheral neuropathy.

Blesneac I, Themistocleous A, Fratter C, Conrad L, Ramirez J, Cox J Pain. 2017; 159(3):469-480.

PMID: 29176367 PMC: 5828379. DOI: 10.1097/j.pain.0000000000001116.

Physiological and Pathophysiological Insights of Nav1.4 and Nav1.5 Comparison.

Loussouarn G, Sternberg D, Nicole S, Marionneau C, LE Bouffant F, Toumaniantz G Front Pharmacol. 2016; 6:314.

PMID: 26834636 PMC: 4712308. DOI: 10.3389/fphar.2015.00314.

References

Li Q, Huang H, Liu G, Lam K, Rutberg J, Green M . Gain-of-function mutation of Nav1.5 in atrial fibrillation enhances cellular excitability and lowers the threshold for action potential firing. Biochem Biophys Res Commun. 2009; 380(1):132-7. DOI: 10.1016/j.bbrc.2009.01.052. View

Remme C, Bezzina C . Genetic modulation of cardiac repolarization reserve. Heart Rhythm. 2007; 4(5):608-10. DOI: 10.1016/j.hrthm.2007.02.025. View

Makiyama T, Akao M, Shizuta S, Doi T, Nishiyama K, Oka Y . A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation. J Am Coll Cardiol. 2008; 52(16):1326-34. DOI: 10.1016/j.jacc.2008.07.013. View

Remme C, Wilde A, Bezzina C . Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations. Trends Cardiovasc Med. 2008; 18(3):78-87. DOI: 10.1016/j.tcm.2008.01.002. View

Valdivia C, Ackerman M, Tester D, Wada T, McCormack J, Ye B . A novel SCN5A arrhythmia mutation, M1766L, with expression defect rescued by mexiletine. Cardiovasc Res. 2002; 55(2):279-89. DOI: 10.1016/s0008-6363(02)00445-5. View

Ruan Y, Denegri M, Liu N, Bachetti T, Seregni M, Morotti S . Trafficking defects and gating abnormalities of a novel SCN5A mutation question gene-specific therapy in long QT syndrome type 3. Circ Res. 2010; 106(8):1374-83. DOI: 10.1161/CIRCRESAHA.110.218891. View

McCormick K, Srinivasan J, White K, Scheuer T, Catterall W . The extracellular domain of the beta1 subunit is both necessary and sufficient for beta1-like modulation of sodium channel gating. J Biol Chem. 1999; 274(46):32638-46. DOI: 10.1074/jbc.274.46.32638. View

Jeck C, Boyden P . Age-related appearance of outward currents may contribute to developmental differences in ventricular repolarization. Circ Res. 1992; 71(6):1390-403. DOI: 10.1161/01.res.71.6.1390. View

Lupoglazoff J, Cheav T, Baroudi G, Berthet M, Denjoy I, Cauchemez B . Homozygous SCN5A mutation in long-QT syndrome with functional two-to-one atrioventricular block. Circ Res. 2001; 89(2):E16-21. DOI: 10.1161/hh1401.095087. View

10.

Nof E, Cordeiro J, Perez G, Scornik F, Calloe K, Love B . A common single nucleotide polymorphism can exacerbate long-QT type 2 syndrome leading to sudden infant death. Circ Cardiovasc Genet. 2010; 3(2):199-206. PMC: 2858238. DOI: 10.1161/CIRCGENETICS.109.898569. View

11.

Arnestad M, Crotti L, Rognum T, Insolia R, Pedrazzini M, Ferrandi C . Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation. 2007; 115(3):361-7. DOI: 10.1161/CIRCULATIONAHA.106.658021. View

12.

Chanda B, Bezanilla F . Tracking voltage-dependent conformational changes in skeletal muscle sodium channel during activation. J Gen Physiol. 2002; 120(5):629-45. PMC: 2229551. DOI: 10.1085/jgp.20028679. View

13.

Kyndt F, Probst V, POTET F, Demolombe S, Chevallier J, Baro I . Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Circulation. 2001; 104(25):3081-6. DOI: 10.1161/hc5001.100834. View

14.

Moss A, Zareba W, Schwarz K, Rosero S, McNitt S, Robinson J . Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome. J Cardiovasc Electrophysiol. 2008; 19(12):1289-93. PMC: 2614458. DOI: 10.1111/j.1540-8167.2008.01246.x. View

15.

Ackerman M, Siu B, STURNER W, Tester D, Valdivia C, Makielski J . Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA. 2001; 286(18):2264-9. DOI: 10.1001/jama.286.18.2264. View

16.

Calloe K, Cordeiro J, Di Diego J, Hansen R, Grunnet M, Olesen S . A transient outward potassium current activator recapitulates the electrocardiographic manifestations of Brugada syndrome. Cardiovasc Res. 2008; 81(4):686-94. PMC: 2642600. DOI: 10.1093/cvr/cvn339. View

17.

Shimoni Y, Fiset C, Clark R, Dixon J, McKinnon D, Giles W . Thyroid hormone regulates postnatal expression of transient K+ channel isoforms in rat ventricle. J Physiol. 1997; 500 ( Pt 1):65-73. PMC: 1159359. DOI: 10.1113/jphysiol.1997.sp021999. View

18.

Makita N, Bennett P, George Jr A . Molecular determinants of beta 1 subunit-induced gating modulation in voltage-dependent Na+ channels. J Neurosci. 1996; 16(22):7117-27. PMC: 6578941. View

19.

Lehtonen A, Fodstad H, Laitinen-Forsblom P, Toivonen L, Kontula K, Swan H . Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes. Heart Rhythm. 2007; 4(5):603-7. DOI: 10.1016/j.hrthm.2007.01.019. View

20.

West J, Patton D, Scheuer T, Wang Y, Goldin A, Catterall W . A cluster of hydrophobic amino acid residues required for fast Na(+)-channel inactivation. Proc Natl Acad Sci U S A. 1992; 89(22):10910-4. PMC: 50452. DOI: 10.1073/pnas.89.22.10910. View